Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Weekly Wrap 29 September

Grady Wulff
September 29, 2023

Morning Bell 29 September

Sam Kanaan
September 29, 2023

Morning Bell 28 September

Grady Wulff
September 28, 2023

Morning Bell 27 September

Grady Wulff
September 27, 2023

Morning Bell 26 September

Sam Kanaan
September 26, 2023

Morning Bell 25 September

Grady Wulff
September 25, 2023

Morning Bell 22 September

Sam Kanaan
September 22, 2023

Morning Bell 21 September

Sophia Mavridis
September 21, 2023

Morning Bell 20 September

Sam Kanaan
September 20, 2023

Morning Bell 19 September

Sophia Mavridis
September 19, 2023

Morning Bell 18 September

Sam Kanaan
September 18, 2023

Weekly Wrap 15 September

Grady Wulff
September 15, 2023